William Nyberg

William Nyberg is a newly appointed principal investigator at the Karolinska Institute. Building on scientific discoveries as a postdoc in Justin Eyquem’s research lab at UCSF, his lab focuses on reprogramming T cells in vivo using advanced genetical engineering for therapeutic purposes. This is done primarily with the use of chimeric antigen receptors (CAR), but we are also exploring the use of other synthetic receptors and therapeutic TCR sequences to develop new T cell therapies against cancers.